Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

705 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tamoxifen therapy for patients with breast cancer.
Neven P, Joensuu H, Osborne K, Cardoso F, Loibl S, Linn S, Goldhirsch A, Ortmann O, Senn HJ, Hayes DF. Neven P, et al. Among authors: goldhirsch a. Lancet. 2013 Jun 15;381(9883):2078. doi: 10.1016/S0140-6736(13)61237-4. Lancet. 2013. PMID: 23769226 No abstract available.
Depression and degree of acceptance of adjuvant cytotoxic drugs.
Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Lancet. 2000 Oct 14;356(9238):1326-7. doi: 10.1016/S0140-6736(00)02821-X. Lancet. 2000. PMID: 11073026
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Among authors: goldhirsch a. Lancet. 2008 Jan 5;371(9606):29-40. doi: 10.1016/S0140-6736(08)60069-0. Lancet. 2008. PMID: 18177773 Review.
705 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page